What a scientific congress means in the Information Age Editorial by Fabrice André President of the European Society for Medical Oncolgy (ESMO)
In recent years, it has become increasingly clearer that the way oncology data is generated, disseminated and accessed is changing. Results are shared instantly through digital platforms, discussed in real time on social media, and published online at a pace that can...
NEWS FROM EASD Interview with Prof. Francesco Giorgino President of the European Association for the Study of Diabetes (EASD)
Francesco Giorgino, M.D., Ph.D. is a Professor of Endocrinology and Chairman of the Department of Precision and Regenerative Medicine and Ionian Area at the University of Bari Aldo Moro, Bari, Italy. He is also Chief of the Division of Endocrinology at the University...
Anabolic steroids linked to serious heart damage in weightlifters; stopping them may aid recovery
Long-term use of anabolic-androgenic steroids (AAS) has serious consequences for the heart, according to a new study that has been following weightlifters for nearly 10 years. The study, published today (Tuesday) in European Heart Journal Cardiovascular Imaging, found...
The European Association for the Study of Diabetes (EASD) Annual Meeting
Study across eight European countries shows that screening for type 1 diabetes can be effectively implemented in children across Europe (EDENT1FI) Study screened children across Germany, UK, Italy, Denmark, Sweden, Czechia, Portugal, Poland Around 1 in 45 children...
The European Association for the Study of Diabetes (EASD) Annual Meeting
Very low carbohydrate diets linked to health benefits in children with type 1 diabetes, largest study of its kind finds Very low carbohydrate (VLC) diets may be associated with health benefits in children with type 1 diabetes (T1D) and were not associated with...
The European Association for the Study of Diabetes (EASD) Annual Meeting
Nationwide study in Norway shows a relative 11% increase in incidence of type 1 diabetes in children aged 0.5 to 5 years after nationwide introduction of rotavirus vaccine, but secondary analyses suggest vaccine probably not the cause New research were presented at...
From promise to patient impact: New European initiative aims to accelerate AI in cardiovascular care
A new EU-funded flagship initiative to harness the power of health data and artificial intelligence (AI) across the continuum of cardiovascular care has been launched, with funding from the EU4Health programme. Cardiovascular diseases (CVDs) remain the leading cause...
Know your numbers – experts welcome first-ever EU Screening Week and encourage citizens across Europe to check their blood pressure, cholesterol and blood sugar
Milan, Italy – 29 September 2026: At a dedicated press conference at the EASD Annual Meeting in Milan, organised by the European Diabetes Forum (EUDF), three leading European cardiometabolic scientific associations - the European Society of Cardiology (ESC), the...
Catheter ablation does not improve quality of life related to atrial fibrillation
Catheter ablation is widely performed to treat atrial fibrillation (AF) but evidence on whether the procedure improves patients’ quality of life related to AF is lacking. In the PVI-SHAM-AF trial, both catheter ablation and a sham intervention improved AF-related...
New research shows transcatheter repair reduces death and heart failure hospitalisation in severe tricuspid regurgitation vs. medical therapy alone
ESC CONGRESS 2026 Severe tricuspid regurgitation is a heart valve disorder associated with debilitating symptoms and increased risk of death. The TRIC-I-HF trial studied transcatheter valve repair plus medical therapy vs. medical therapy alone in patients with severe...
Record-breaking ESC Congress 2026 puts new life-saving cardiovascular science in the spotlight
A total of 33,800 healthcare professionals from 170 countries participated in ESC Congress 2026, the largest ever flagship meeting of the European Society of Cardiology (ESC). This year’s congress took place in Munich, Germany, and focused on the spotlight theme...
Implantable cardioverter-defibrillators may benefit certain younger patients with mild–moderate heart dysfunction
Key takeaways Sudden cardiac death occurs in patients with heart failure and left ventricular ejection fraction (LVEF) greater than 35% but they are not currently eligible for an implantable cardioverter-defibrillator (ICD). The CMR GUIDE trial evaluated whether an...
New global definition of myocardial infarction aims to improve diagnosis, treatment and patient understanding
Munich, Germany – 28 August 2026: When a myocardial infarction, such as a heart attack, occurs, being able to classify its type can improve diagnosis and treatment. For the first time, a universal definition of myocardial infarction has been developed and published by...
Implantable cardioverter-defibrillators may benefit certain younger patients with mild–heart dysfunction
Munich, Germany – 28 August 2026: An implantable cardioverter-defibrillator did not improve the primary endpoint overall in the CMR GUIDE trial but younger patients appeared to benefit, according to results presented in a Hot Line session today at ESC Congress 20261 and...
ESC Congress 2026 Heart, body and mind – the first ESC Guidelines highlight the many benefits of cardiac rehabilitation
Key takeaways The first dedicated ESC Guidelines on cardiac rehabilitation have been published today in the European Heart Journal. The new guidelines highlight how cardiac rehabilitation can improve quality of life, physical fitness, confidence and mental...
ESMO Gastrointestinal Cancers Congress 2026
Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery Munich, Germany – A blood test may help identify which patients with colorectal cancer that has spread to the liver are most...
Romanian Robotic & Metabolic Surgery Days 2026
Dear Colleagues, It is our great pleasure to invite you to the Romanian Robotic & Metabolic Surgery Days 2026, held under the theme “Bringing Better Care to All.” It became a tradition for the two professional associations, RAES and RSMS to organize successful...
Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery
Date: 03 Jul 2026 Munich, Germany – A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers...
ESC Congress 2026: Transforming innovative ideas into clinical reality
Key takeaways The world's leading cardiology experts will convene in Munich for ESC Congress 2026. The event takes place from 28 to 31 August, with the press programme beginning on 27 August. This year’s spotlight on artificial intelligence will explore the potential...
Common food preservatives linked to high blood pressure and heart disease
Key takeaways The study of 112,395 people includes a detailed analysis of diet and food ingredients. Researchers found eight preservative food additives linked to high blood pressure or cardiovascular disease. The highest risks were in people who ate the most...
Experts call for women’s heart centres to tackle inequality in diagnosis & care
Key takeaways: Cardiovascular disease is the leading cause of death in women. Women are more likely to have undiagnosed and untreated cardiovascular disease. Dedicated women's heart centres are needed to improve diagnosis, treatment and care. Sophia Antipolis,...
ESMO Breast Cancer 2026 – Precision Oncology, Molecular Monitoring and the Evolving Paradigm of Survivorship Care
The scientific programme of ESMO Breast Cancer 2026 highlighted the accelerating integration of precision oncology into breast cancer prevention, disease monitoring, and survivorship care. Across sessions dedicated to early detection, translational research, and early...
National Study Examines Genetic Testing to Inform Follow-up Care for Cancer Survivors A study presented at the ESMO Breast Cancer 2026 congress
Date: 07 May 2026 BERLIN, Germany – Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are...
Opening Ceremony of ESMO Breast Cancer 2026 Sets the Tone for Innovation and Global Collaboration
The ESMO Breast Cancer 2026 officially commenced on Wednesday, May 6, with a distinguished opening ceremony and award lecture that underscored the rapid pace of scientific advancement and the critical role of international collaboration in improving breast cancer...
